In December 2018, Jianjia received investment from PricewaterhouseCoopers and Kefa Capital. In early 2020, it completed the investment of tens of millions of Baidu Ventures. In August 2020, it completed the investment of well-known investment institutions Hillhouse Capital, Fosun Group, and Baidu Ventures over 100 million investment. In May 2021, Jianjia received hundreds of millions of C round of financing, led by LYFE Capital, and co-invested by SoftBank China Capital, and the old shareholders Hillhouse Ventures and Fosun Pharma continue to raise funds.
